Patents by Inventor Benjamin Pelcman

Benjamin Pelcman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLUOROPHENYL BETA-HYDROXYETHYLAMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCAEMIA
    Publication number: 20230364035
    Abstract: There is herein provided a compound of formula (I).
    Type: Application
    Filed: April 11, 2023
    Publication date: November 16, 2023
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • HYDROXYLBENZYL AZABICYCLO[2.2.1]HEPTAN-1-ANE DRIVATIVES AND MEDICAL USES THEREOF
    Publication number: 20230365572
    Abstract: There is provided herein a compound of formula I or a pharmaceutically acceptable salt thereof, wherein R1 and the ring comprising Q1 to Q5 have meanings provided in the description.
    Type: Application
    Filed: September 23, 2021
    Publication date: November 16, 2023
    Inventors: Ilga Mutule, Benjamin Pelcman, Tore Bengtsson
  • Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
    Patent number: 11793774
    Abstract: There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1, R2, R3, R4 and n have meanings as provided in the description.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: October 24, 2023
    Assignee: ATROGI AB
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
    Patent number: 11648216
    Abstract: There is herein provided a compound of formula (I).
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: May 16, 2023
    Assignee: ATROGI AB
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia
    Patent number: 11427539
    Abstract: There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1, ring A, m and n have meanings as provided in the description.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: August 30, 2022
    Assignee: ATROGI AB
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • HETEROARYL(HETEROCYCLYL)METHANOL COMPOUNDS USEFUL IN THE TREATMENT OF HYPERGLYCAEMIA
    Publication number: 20220194920
    Abstract: There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, wherein the ring comprising Q1 to Q5, R1, m, X1 and ring A have meanings as provided in the description.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 23, 2022
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
    Patent number: 11357757
    Abstract: There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the ring containing Q1 to Q5, and the groups R1, R2 and R3, have meanings as provided in the description.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: June 14, 2022
    Assignee: ATROGI AB
    Inventor: Benjamin Pelcman
  • SULFINYLPYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER
    Publication number: 20220177430
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3, R4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Application
    Filed: December 15, 2021
    Publication date: June 9, 2022
    Inventors: Benjamin Pelcman, Owe Orwar, William Stafford, Kjell Andersson
  • HETEROCYCLYL(PHENYL)METHANOL COMPOUNDS USEFUL IN THE TREATMENT OF HYPERGLYCAEMIA
    Publication number: 20220152004
    Abstract: There is herein provided a compound of formula I or a pharmaceutically acceptable salt thereof, wherein X, R1, R2, R3, ring A, n and y have meanings as provided in the description.
    Type: Application
    Filed: March 20, 2020
    Publication date: May 19, 2022
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA
    Publication number: 20220133703
    Abstract: There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the ring containing Q1 to Q5, and the groups R1, R2 and R3, have meanings as provided in the description.
    Type: Application
    Filed: January 13, 2022
    Publication date: May 5, 2022
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER
    Publication number: 20220119348
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Application
    Filed: October 29, 2021
    Publication date: April 21, 2022
    Applicant: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede
  • Sulfinylpyridines and their use in the treatment of cancer
    Patent number: 11208384
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3, R4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: December 28, 2021
    Assignee: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, Owe Orwar, William Stafford, Kjell Andersson
  • Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
    Patent number: 11168069
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: November 9, 2021
    Assignee: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, William Stafford
  • COMBINATIONS OF ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES
    Publication number: 20210338603
    Abstract: There is herein provided pharmaceutical formulations and kits-of-parts comprising a ?2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, and a ?3-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof. This combination of active agents finds particular utility in the treatment of type 2 diabetes.
    Type: Application
    Filed: May 14, 2021
    Publication date: November 4, 2021
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
    Patent number: 11161815
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: November 2, 2021
    Assignee: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede
  • Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
    Patent number: 11028067
    Abstract: There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: June 8, 2021
    Assignee: Oblique Therapeutics AB
    Inventors: Benjamin Pelcman, Edgars Suna, William Stafford, Martins Priede
  • HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA
    Publication number: 20210030731
    Abstract: There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the ring containing Q1 to Q5, and the groups R1, R2 and R3, have meanings as provided in the description.
    Type: Application
    Filed: September 13, 2018
    Publication date: February 4, 2021
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • COMBINATIONS OF ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES
    Publication number: 20200315993
    Abstract: There is herein provided pharmaceutical formulations and kits-of-parts comprising a ?2-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof, and a ?3-adrenergic receptor agonist, or a pharmaceutically acceptable salt thereof. This combination of active agents finds particular utility in the treatment of type 2 diabetes.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • BETA-HYDROXY HETEROCYCLIC AMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCAEMIA
    Publication number: 20200277259
    Abstract: There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1, ring A, m and n have meanings as provided in the description.
    Type: Application
    Filed: September 13, 2018
    Publication date: September 3, 2020
    Inventors: Benjamin Pelcman, Tore Bengtsson
  • FLUOROPHENYL BETA-HYDROXYETHYLAMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCAEMIA
    Publication number: 20200268688
    Abstract: There is herein provided a compound of formula (I).
    Type: Application
    Filed: September 13, 2018
    Publication date: August 27, 2020
    Inventors: Benjamin Pelcman, Tore Bengtsson